Niki BioSolutions NIKI
NASDAQ NIKI
$8.58 +0.38 (+4.63%)
At close: Aug 21, 2026 · 4:00 PM EDT

Niki BioSolutions, Inc. (NIKI) Revenue (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Revenue came in at -$158432.0 in Q4 2025, down 167.71% YoY from $233977.0 in Q4 2024, and down 154.86% on a QoQ basis from $288787.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Revenue (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 3 years of Revenue data on file, last reported at -$158432.0 in Q4 2025.

  • Quarterly Revenue fell 167.71% year-over-year to -$158432.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $573175.0 (changed N/A YoY) and the FY2025 annual result came in at $631729.0, down 52.12% from the prior year.
  • Revenue retreated to -$158432.0 in Q4 2025, from $288787.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $288787.0 in Q3 2025 to a low of -$158432.0 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Nov 30, 2025 -158,432.00
Aug 31, 2025 288,787.00
Nov 30, 2024 233,977.00
Aug 31, 2024 208,843.00
Dec 31, 2017 -514,354.00